Advance Care Planning and Care Coordination for People With Parkinson's Disease
NCT05954013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189
Last updated 2023-07-20
Summary
Background: People with Parkinson's disease (PD), including parkinsonisms, experience complex motor and non-motor symptoms, which become more hindering in the advanced stages of PD. Advance care planning (ACP) enables individuals to define goals and preferences for future medical treatment and serves to ensure that people receive treatment and care that is in line with their preferences during serious chronic illness. The effectiveness of ACP for PD is currently unknown.
Methods: The investigators will evaluate the effectiveness of a multicenter, open-label randomized controlled trial, with a parallel group design in seven European countries (Austria, Estonia, Germany, Greece, Italy, Sweden and United Kingdom). The "PD\_Pal intervention" comprises (1) several consultations with a trained nurse who will perform ACP conversations and support care coordination and (2) use of a patient-directed "Parkinson Support Plan-workbook". The intervention group will be compared to a care-as-usual group. Documented ACP-decisions in the medical records/patient's central file assessed at 6 months after baseline will be the primary endpoint. Secondary endpoints include patients' and family caregivers' quality of life, perceived care coordination, patients' symptom burden, and cost-effectiveness. Assessments will take place at baseline, 6 months after baseline and 12 months after baseline. In parallel, we will perform a process evaluation, to understand the feasibility of the intervention.
Hypothesis: The investigators hypothesize that the PD\_Pal intervention will result in an increased number of participants with ACP documentation in the medical records/patient's central file, as compared to care-as-usual. Secondly, the investigators expect that, due to the PD\_Pal intervention, patients and their FC will experience better care coordination, better quality of life, a reduced patient symptom burden and the FC will experience a reduction in caregiver burden.
Conditions
- Parkinson Disease
- Parkinsonism
Interventions
- BEHAVIORAL
-
PD_Pal intervention
The PD\_Pal intervention will be delivered by a nurse that is specifically trained to deliver the PD\_Pal intervention, i.e. the PD\_Pal nurse. In the PD\_Pal intervention, the patient, family caregiver and PD\_Pal nurse complete four steps wherein they discuss and compose a: 1) Individual care plan; 2) Proactive care plan; 3) Quality of life and end-of-life plan and; 4) Coordination and revision plan. Together these steps lead to the Parkinson Support Plan. To facilitate patients in taking these steps, all patients receive a Parkinson Support Plan workbook. This workbook consists of information and questions aligned with the four steps. Patients can utilize this workbook before, during, or after the conversations with the PD\_Pal nurse.
Sponsors & Collaborators
-
University of Padova
collaborator OTHER -
University of Ioannina
collaborator OTHER -
University College, London
collaborator OTHER -
Estonian Movement Disorders Society
collaborator UNKNOWN -
Paracelsus Medical University
collaborator OTHER -
Philipps University Marburg
collaborator OTHER -
Skane University Hospital
collaborator OTHER -
Mediolanum Cardio Research
collaborator OTHER -
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Angelo Antonini, MD, PhD · University of Padova
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-06
- Primary Completion
- 2023-03-17
- Completion
- 2023-03-17
Countries
- Austria
- Estonia
- Germany
- Greece
- Italy
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease
NCT02055261 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"
NCT05251298 ·Status: UNKNOWN ·Phase: NA
-
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
NCT01014858 ·Status: TERMINATED ·Phase: PHASE3
-
Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation
NCT02585154 ·Status: COMPLETED ·Phase: NA
-
Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain+ Parkinson's Network
NCT06479083 ·Status: RECRUITING ·Phase: NA
-
Subthalamic Deep Brain Stimulation (DBS) in Parkinson's Disease
NCT02012647 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Crossover Versus Stabilometric Platform in Parkinson's Disease
NCT02098577 ·Status: COMPLETED
-
Action Observation Treatment in Parkinson's Patients
NCT04181918 ·Status: UNKNOWN ·Phase: NA
-
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study
NCT01747655 ·Status: COMPLETED
-
Movement Disorders Analysis Using a Deep Learning Approach
NCT04974034 ·Status: COMPLETED
-
Mobile Decision Support System for Nurse Management of Neuromodulation Therapy
NCT02474459 ·Status: COMPLETED ·Phase: NA
-
Integrated Parkinson Care Networks : Care in Parkinson Disease
NCT04915209 ·Status: UNKNOWN ·Phase: NA
-
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
NCT02401308 ·Status: TERMINATED ·Phase: NA
-
Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease
NCT02154724 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease
NCT01504178 ·Status: COMPLETED ·Phase: PHASE3
-
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
NCT03593512 ·Status: COMPLETED ·Phase: NA
-
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034 ·Status: RECRUITING
-
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
NCT07227896 ·Status: NOT_YET_RECRUITING
-
Data-Driven Characterization of Neuronal Markers During Deep Brain Stimulation for Patients With Parkinson's Disease
NCT03079960 ·Status: UNKNOWN ·Phase: NA
-
Interposed Nucleus aDBS for Ataxia
NCT07325487 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of Adaptive Deep Brain Stimulation
NCT03724734 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
NCT04287465 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa
NCT07284342 ·Status: RECRUITING
-
Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia
NCT02524886 ·Status: TERMINATED ·Phase: NA
-
Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient
NCT01274832 ·Status: UNKNOWN